Anne‐Françoise Tilkin‐Mariamé

Immunology and Microbiology · Life Sciences

12h-index483citations39works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(24), Cancer Immunotherapy and Biomarkers(15), CAR-T cell therapy research(14), Immune Cell Function and Interaction(8), Cell Adhesion Molecules Research(4)

Publications39 total

Supplementary Figure S6 from Blocking Tumor Necrosis Factor α Enhances CD8 T-cell–Dependent Immunity in Experimental Melanoma
2023Open Access
Supplementary information from Blocking Tumor Necrosis Factor α Enhances CD8 T-cell–Dependent Immunity in Experimental Melanoma
2023Open Access
Supplementary Figure S4 from Blocking Tumor Necrosis Factor α Enhances CD8 T-cell–Dependent Immunity in Experimental Melanoma
2023Open Access
Supplementary Figure S5 from Blocking Tumor Necrosis Factor α Enhances CD8 T-cell–Dependent Immunity in Experimental Melanoma
2023Open Access
Supplementary Figure S5 from Blocking Tumor Necrosis Factor α Enhances CD8 T-cell–Dependent Immunity in Experimental Melanoma
2023Open Access
Supplementary Figure S2 from Blocking Tumor Necrosis Factor α Enhances CD8 T-cell–Dependent Immunity in Experimental Melanoma
2023Open Access
Supplementary Figure S7 from Blocking Tumor Necrosis Factor α Enhances CD8 T-cell–Dependent Immunity in Experimental Melanoma
2023Open Access
Supplementary Figure S3 from Blocking Tumor Necrosis Factor α Enhances CD8 T-cell–Dependent Immunity in Experimental Melanoma
2023Open Access
Supplementary Figure S1 from Blocking Tumor Necrosis Factor α Enhances CD8 T-cell–Dependent Immunity in Experimental Melanoma
2023Open Access
Supplementary Figure S2 from Blocking Tumor Necrosis Factor α Enhances CD8 T-cell–Dependent Immunity in Experimental Melanoma
2023Open Access
Data from Blocking Tumor Necrosis Factor α Enhances CD8 T-cell–Dependent Immunity in Experimental Melanoma
2023Open Access
Supplementary Figure S6 from Blocking Tumor Necrosis Factor α Enhances CD8 T-cell–Dependent Immunity in Experimental Melanoma
2023Open Access
Supplementary Figure S7 from Blocking Tumor Necrosis Factor α Enhances CD8 T-cell–Dependent Immunity in Experimental Melanoma
2023Open Access
Supplementary Figure S3 from Blocking Tumor Necrosis Factor α Enhances CD8 T-cell–Dependent Immunity in Experimental Melanoma
2023Open Access
Data from Blocking Tumor Necrosis Factor α Enhances CD8 T-cell–Dependent Immunity in Experimental Melanoma
2023Open Access
Supplementary information from Blocking Tumor Necrosis Factor α Enhances CD8 T-cell–Dependent Immunity in Experimental Melanoma
2023Open Access
Supplementary Figure S4 from Blocking Tumor Necrosis Factor α Enhances CD8 T-cell–Dependent Immunity in Experimental Melanoma
2023Open Access
Supplementary Figure S1 from Blocking Tumor Necrosis Factor α Enhances CD8 T-cell–Dependent Immunity in Experimental Melanoma
2023Open Access
5′ Region Large Genomic Rearrangements in the BRCA1 Gene in French Families: Identification of a Tandem Triplication and Nine Distinct Deletions with Five Recurrent Breakpoints
Cancers·2021· 12 citedOpen Access
Colon-specific immune microenvironment regulates cancer progression versus rejection
2020· 4 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Philippe Rochaix(25), Isabelle Lajoie‐Mazenc(21), Florie Bertrand(20), Julia Rochotte(19), Céline Colacios(19), Anne Montfort(19), Christian Touriol(19), Nathalie Andrieu‐Abadie(19), Thierry Levade(19), Hervé Benoist(19), Bruno Ségui(19), Gilles Favre(10), Bernard Mariamé(7), Christine Pich-Bavastro(6), Guillaume Sarrabayrouse(5), Iotefa Teiti(5), Carine Cormary(4), Franck Gallardo(4), Christel Devaud(3), Nathalie Vergnolle(3)